Previous 10 | Next 10 |
22nd Century’s Proprietary VLN ® King and VLN ® Menthol King Poised to Play a Central Role in Making FDA’s Reduced Nicotine Mandate Feasible MRTP Authorization of VLN ® King and VLN ® Menthol King Will Serve as a Major Cataly...
XXII is awaiting MRTP authorization from the FDA and, once granted, the company will bring to market its VLN cigarettes. The company is also positioned, via its partnerships, to introduce its high THC cannabis genetics to the market. Currently, the company operates at a net loss, ...
Management seems confident of MRTP approval. The VLN cigarette has no real competition in the combustible space. We advise using this binary event to play the high implied volatility currently on offer. For further details see: 22nd Century Group: Why We Use Options For ...
WILLIAMSVILLE, N.Y., March 19, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII ), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, today congratulated Xavier Becerra as t...
Shares of 22nd Century Group (NYSEMKT: XXII) are up a strong 14.6% in 11:45 a.m. EST trading Friday after the "plant biotechnology" company reported fourth-quarter earnings yesterday. 22nd Century Group didn't "beat" earnings, exactly. Its $0.05 per-share reported loss was worse...
Gainers: NLS Pharmaceutics (NLSP) +87%.Entera Bio (ENTX) +72%.Seelos Therapeutics (SEEL) +69%.Ebang International (EBON) +43%.Perpetua Resources (PPTA) +27%.AMREP (AXR) +21%.22nd Century (XXII) +19%.Aemetis (AMTX) +18%.LendingClub (LC) +18%.MicroVision (MVIS) +17%.Losers: Marker The...
WILLIAMSVILLE, N.Y., March 12, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII ), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, today announced that it has received an...
Image source: The Motley Fool. 22nd Century Group (NYSEMKT: XXII) Q4 2020 Earnings Call Mar 11, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: 22nd Century Group (XXII) Q4 2020 Earnings Call Transcript
22nd Century Group, Inc. (XXII) Q4 2020 Earnings Conference Call March 11, 2021 8:00 AM ET Company Participants Mei Kuo – Director-Communications and Investor Relations Jim Mish – Chief Executive Officer Mike Zercher – President and Chief Operating Officer John Franzino &...
The following slide deck was published by 22nd Century Group, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: 22nd Century Group, Inc. 2020 Q4 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
22nd Century Group Inc Company Name:
XXII Stock Symbol:
NYSE Market:
22nd Century Group Inc Website:
Patented, Fully Water Dispersing, Biodegradable Solution for World's Most Littered Item Mocksville, North Carolina--(Newsfile Corp. - July 10, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announce...
Mocksville, North Carolina--(Newsfile Corp. - July 9, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a new agreement for full-scale commercial rollout of its VLN® reduced nicotine cont...
Mocksville, North Carolina--(Newsfile Corp. - June 25, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a $1.5 million reduction in its secured debt via a paydown of the GVB secured promissor...